AI assistant
Sending…
Medpace Holdings, Inc. — Director's Dealing 2021
Oct 28, 2021
30442_dirs_2021-10-28_7d9ed4a6-96ff-4d54-9c69-7ee182ef4ee8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-10-26
Reporting Person: Keating Ashley M. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-26 | Common Stock | M | 2000 | $54.99 | Acquired | 2000 | Direct |
| 2021-10-26 | Common Stock | S | 2000 | $210 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-26 | STOCK OPTION (RIGHT TO BUY) | $54.99 | M | 2000 | Disposed | 2026-05-17 | Common Stock (2000) | Direct |
Footnotes
F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2: The option vested the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.
More from Medpace Holdings, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 22
Annual Report
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 17